Literature DB >> 15978517

Sleep disturbance in mild to moderate Alzheimer's disease.

Maria Moran1, C A Lynch, C Walsh, R Coen, D Coakley, B A Lawlor.   

Abstract

BACKGROUND AND
PURPOSE: To determine the prevalence of sleep disturbance in a memory clinic population of Alzheimer's disease (AD) patients and identify its clinical correlates. PATIENTS AND METHODS: Data from 215 attendees at a memory clinic, who were diagnosed with Alzheimer's disease, were examined. This included data from cognitive, functional and neuropsychological assessments. Sleep disturbance was determined using the question about diurnal rhythm disturbance on the BEHAVE-AD questionnaire. Two groups, with and without sleep disturbance, were compared. Group differences were analysed using univariate analysis and stepwise logistic regression analysis.
RESULTS: The prevalence of sleep disturbance in this sample was 24.5%. The BEHAVE-AD 'aggressiveness' (P=0.009) and 'global rating' (P=0.029) (a measure of global impact of behavioural disturbance) were found to be significant predictors of sleep disturbance in AD.
CONCLUSIONS: Sleep disturbance in AD is associated with other behavioural symptoms, notably aggressiveness. Sleep disturbance in AD has significant impact on the patient and/or caregiver. Consideration of co-morbid behavioural symptoms may aid the clinician in choosing a suitable treatment for sleep disturbance in AD.

Entities:  

Mesh:

Year:  2005        PMID: 15978517     DOI: 10.1016/j.sleep.2004.12.005

Source DB:  PubMed          Journal:  Sleep Med        ISSN: 1389-9457            Impact factor:   3.492


  83 in total

1.  A sleep continuity scale in Alzheimer's disease: validation and relationship with cognitive and functional deterioration.

Authors:  R Manni; E Sinforiani; C Zucchella; M Terzaghi; C Rezzani
Journal:  Neurol Sci       Date:  2012-05-24       Impact factor: 3.307

Review 2.  The management of sleep and circadian disturbance in patients with dementia.

Authors:  Qiuping Pearl Zhou; Lorena Jung; Kathy C Richards
Journal:  Curr Neurol Neurosci Rep       Date:  2012-04       Impact factor: 5.081

3.  Sleep disturbance among older adults in assisted living facilities.

Authors:  Constance H Fung; Jennifer L Martin; Carol Chung; Lavinia Fiorentino; Michael Mitchell; Karen R Josephson; Stella Jouldjian; Cathy Alessi
Journal:  Am J Geriatr Psychiatry       Date:  2012-06       Impact factor: 4.105

Review 4.  Bidirectional relationship between sleep and Alzheimer's disease: role of amyloid, tau, and other factors.

Authors:  Chanung Wang; David M Holtzman
Journal:  Neuropsychopharmacology       Date:  2019-08-13       Impact factor: 7.853

Review 5.  Targeting amyloid clearance in Alzheimer's disease as a therapeutic strategy.

Authors:  Natalia N Nalivaeva; Anthony J Turner
Journal:  Br J Pharmacol       Date:  2019-03-11       Impact factor: 8.739

Review 6.  It's complicated: The relationship between sleep and Alzheimer's disease in humans.

Authors:  Brendan P Lucey
Journal:  Neurobiol Dis       Date:  2020-07-29       Impact factor: 5.996

Review 7.  Sleep in older adults and in subjects with dementia.

Authors:  Helmut Frohnhofen; Jeanina Schlitzer; Nikolaus Netzer
Journal:  Z Gerontol Geriatr       Date:  2017-07-18       Impact factor: 1.281

8.  Microtubules modulate melatonin receptors involved in phase-shifting circadian activity rhythms: in vitro and in vivo evidence.

Authors:  Michael J Jarzynka; Deepshikha K Passey; David A Johnson; Nagarjun V Konduru; Nicholas F Fitz; Nicholas M Radio; Mark Rasenick; Susan Benloucif; Melissa A Melan; Paula A Witt-Enderby
Journal:  J Pineal Res       Date:  2008-10-28       Impact factor: 13.007

Review 9.  Sleep as a Therapeutic Target in the Aging Brain.

Authors:  Thierno M Bah; James Goodman; Jeffrey J Iliff
Journal:  Neurotherapeutics       Date:  2019-07       Impact factor: 7.620

Review 10.  Effects of exercise on sleep in neurodegenerative disease.

Authors:  Adeel A Memon; Juliana J Coleman; Amy W Amara
Journal:  Neurobiol Dis       Date:  2020-04-01       Impact factor: 5.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.